Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients

Leukemia Research

Volumn 33, Issue 9, 2009, Pages 1194-1198

  Li, Lin ^a   Liu, Xu Ping ^a   Nie, Ling ^a   Yu, Ming Hua ^a   Zhang, Yue ^a   Qin, Tie Jun ^a   Xiao, Zhi Jian ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Cytogenetics; Karyotype; Myelodysplastic syndromes; Primary

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CHROMOSOME 17; CHROMOSOME 20; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; DISEASE CLASSIFICATION; FEMALE; GENE DELETION; GENE FREQUENCY; HUMAN; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; TRISOMY 8;

ADOLESCENT; ADULT; AGED; CHINA; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; YOUNG ADULT;

EID: 67649255982     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.021     Document Type: Article

References (17)

1. Valent P., Horny H.P., Bennett J.M., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res 31 (2007) 727-736
2. Bernasconi P., Klersy C., Boni M., et al. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 137 (2007) 193-205
3. Chen B., Zhao W.L., Jin J., et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19 (2005) 767-775
4. Matsuda A., Germing U., Jinnai I., et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 106 (2005) 2633-2640
5. Lee J.H., Lee J.H., Shin Y.R., et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 17 (2003) 305-313
6. Intragumtornchai T., Prayoonwiwat W., Swasdikul D., et al. Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases. Leuk Res 22 (1998) 453-460
7. Vardiman J.W., Harris N.L., Brunning R.D., et al. The Wor1d Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
8. Greenberg P., Cox C., LeBeau M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89 (1997) 2079-2088
9. Olney H.J., and Le Beau M.M. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes. Leuk Res 31 (2007) 427-434
10. Virtaneva K., Writht F.A., Tanner S.M., et al. Expression profiling reveal fundamental biological differences in acute myeloid leukemia with isolated trosomy 8 and normal cytogenetics. PNAS 98 (2001) 1124-1129
11. Xiao Z., Liu Z., Yu M., et al. Ischromosome 17q in patients with myelodysplastic syndromes: six new cases. Haematologica 88 (2003) 714-715
12. Xiao Z., Zhang M., Liu X., et al. MEL1s, not MEL1, is overexpressed in myelodysplastic symdromes patients with t(1;3)(p36;q21). Leuk Res 30 (2006) 332-334
13. Pfeilstöcker M., Reisner R., Nösslinger T., et al. Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics. Br J Haematol 106 (1999) 455-463
14. Belli C., Acevedo S., Bengio R., et al. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Haematologica 87 (2002) 9-16
15. Lorand-Metze I., Pinheiro M.P., Ribeiro E., et al. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 28 (2004) 587-594
16. Müller-Berndorff H., Haas P.S., Kunzmann R., et al. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: results of a single-center analysis. Ann Hematol 85 (2006) 502-513
17. Navarro I., Ruiz M.A., Cabello A., et al. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients. Leuk Res 30 (2006) 971-977